Nephrology & urology
Kidney & urinary clinical trials
Kidney disease and conditions of the bladder and urinary tract. We’re tracking 4,514 recruiting studies in this area right now.
By phase
- Not applicable2,826
- Phase 2565
- Phase 1366
- Phase 3272
- Phase 1/Phase 2230
- Phase 4196
- Phase 2/Phase 359
Top conditions
- Prostate Cancer654
- Bladder Cancer190
- Acute Kidney Injury137
- Chronic Kidney Diseases131
- Breast Cancer105
- Chronic Kidney Disease105
- Renal Cell Carcinoma81
- Urinary Incontinence63
- Kidney Cancer60
- Colorectal Cancer58
- Ovarian Cancer58
- Lung Cancer54
- Lupus Nephritis53
- Cancer51
- Melanoma50
- Benign Prostatic Hyperplasia48
- Head and Neck Cancer46
- Prostate Cancer (Adenocarcinoma)46
Leading sponsors
- Mayo Clinic63
- National Cancer Institute (NCI)46
- Peking University First Hospital38
- M.D. Anderson Cancer Center36
- Chinese University of Hong Kong34
- Novartis Pharmaceuticals34
- AstraZeneca30
- Memorial Sloan Kettering Cancer Center29
- Assistance Publique - Hôpitaux de Paris28
- University of California, San Francisco28
Where studies are running
- California350
- Alabama111
- Arizona103
- Florida98
- New York96
- Texas92
- Maryland90
- Massachusetts88
- Illinois66
- Minnesota47
Recruiting studies4,514 total
- NCT01793168Recruiting
Rare disease registry and history study
This study keeps a registry (a structured list) of people with rare diseases and may also track how the condition changes over time. It can help researchers better understand rare illnesses and find gaps in care, which may improve future treatments.
Sioux Falls, South DakotaAges Any age - NCT00327860Recruiting
Kidney disease in children study that follows patients over time
This is a long-term study that watches children and young adults with chronic kidney disease to understand how the illness changes and to improve care. You may be asked to complete regular visits and questionnaires, and your kidney function will be tracked over time.
Kansas City, MissouriAges 6 months–22 years - NCT00969111Recruiting
Radiation after prostate surgery for prostate cancer without nodal spread
This trial looks at radiation therapy given after prostate surgery (or if needed later) for prostate cancer where lymph nodes were not involved. It may help patients whose PSA rises or who need additional treatment to reduce the chance the cancer comes back.
Little Rock, ArkansasAges 18 years+ - NCT00381121Recruiting
Kidney and pancreas biopsy participants needed for a research bank
This study collects and stores biological samples from people (including children) who are already getting a kidney and/or pancreas biopsy at the University of Michigan. It helps researchers better understand kidney and pancreas diseases, and participation depends on giving informed consent.
Ann Arbor, MichiganAges Any age - NCT01886950Recruiting
Bone and blood-vessel changes around kidney transplant
This study looks at how bone structure and blood-vessel calcification change before and after a kidney transplant. It may help doctors better understand what to monitor for long-term health after transplantation.
Leuven, Vlaams-BrabantAges 18 years+ - NCT00948116Recruiting
Blood and urine tests to predict kidney injury in diabetes
This study checks whether a set of blood and urine tests can predict “acute kidney injury” (a sudden worsening of kidney function) earlier in people with diabetes who are undergoing a heart procedure. If the tests work, they may help doctors spot kidney trouble sooner and protect your kidneys.
LondonAges 18 years+ - NCT01752738Recruiting
Study of gut microbial metabolites in chronic kidney disease
This trial studies how substances made by gut microbes travel in people with chronic kidney disease. You may be asked to have a planned colonoscopy so researchers can measure intestinal samples and better understand kidney disease.
Leuven, Vlaams BrabantAges 18–85 - NCT00588562Recruiting
Registry for inherited rare kidney stone disorders
This registry collects information from people with certain inherited rare kidney stone conditions. It helps researchers learn about the conditions and supports future studies that may improve care.
Rochester, MinnesotaAges birth–100 years - NCT01953263RecruitingPhase 1/Phase 2
Muscle fragment treatment trial for urinary incontinence
This early-phase trial tests a treatment made from muscle fragments to improve urinary incontinence caused by weakness of the urethral “sphincter” (the valve that holds urine). It may help people with certain types of incontinence, but it also requires meeting several bladder and health criteria for safety.
Winston-Salem, North CarolinaAges 18–75 - NCT00977977RecruitingPhase 2
Rituximab plus cyclosporine for membranous kidney disease
This trial tests whether rituximab (an immune-targeting medicine) plus cyclosporine (another immune medicine) can better control protein leakage in the urine for people with idiopathic membranous nephropathy. It may help reduce long-lasting kidney damage risk when standard treatments like ACE inhibitor or ARB don’t control the protein level.
Bethesda, MarylandAges 18–90 - NCT01913106RecruitingPhase 1/Phase 2
Testing valacyclovir with an added cancer gene in prostate radiation
This Phase 1/2 study tests whether adding a cancer-targeting gene therapy (HSV-tk) and the antiviral medicine valacyclovir to brachytherapy can better treat recurrent prostate cancer in the prostate area. It may help by making cancer cells more vulnerable to the treatment.
Houston, TexasAges Any age - NCT01016613Recruiting
Kidney health study that helps build a tissue and data bank
This study collects health information and biological samples to better understand kidney disease and support future kidney research. It may help your care indirectly by improving how kidney conditions are recognized and studied.
Ann Arbor, MichiganAges Any age - NCT01873235Recruiting
Study for adults with confirmed polycystic kidney disease
This study enrolls adults with autosomal dominant polycystic kidney disease (ADPKD) to better understand the disease and its related changes in the body. It may help researchers find improved ways to track the condition and support future treatments.
Baltimore, MarylandAges 18 years+ - NCT00929006RecruitingEarly Phase 1
Testing progesterone effects on hormone timing during sleep in teens
This early-phase study tests whether a progesterone medicine can change when “luteinizing hormone” (a puberty-related hormone) pulses during wake versus sleep. It focuses on pubertal girls with either normal or higher-than-expected testosterone levels to see how their hormone timing responds.
Charlottesville, VirginiaAges 10–17 - NCT00949819Recruiting
Active surveillance study for localized prostate cancer
This trial studies a “watchful waiting” approach, where doctors closely monitor certain prostate cancers with regular checkups and repeat biopsies. It may help people avoid or delay treatment side effects while watching for signs the cancer needs treatment.
Los Angeles, CaliforniaAges 30–85 - NCT01087333Recruiting
Share blood samples to help study blood cancers and treatments
This study collects human samples (like blood or other specimens) to learn more about hairy cell leukemia and other leukemias. It also helps researchers develop new lab-made immune-based medicines for cancer treatment.
Bethesda, MarylandAges 18 years+ - NCT01109394Recruiting
Help study tumors with sample testing and a research biology library
This study collects tumor (or related) samples to analyze their genes and build a shared research “biobank.” It may help researchers understand cancers better for future diagnosis and treatments.
Washington D.C., District of ColumbiaAges 4 weeks+ - NCT01174121RecruitingPhase 2
Immunotherapy made from your tumor-fighting immune cells
This trial tests a treatment made from your own immune cells (called tumor-infiltrating lymphocytes, or TILs) for certain metastatic cancers. It’s designed for people whose cancer has not responded to standard treatments and who can safely provide a small tumor sample for cell-making.
Bethesda, MarylandAges 18–72 - NCT01194648Recruiting
HIFU treatment for early prostate cancer
This trial studies a focused ultrasound treatment called HIFU for prostate cancer that appears limited to the early stages. It aims to treat cancer within the prostate while avoiding treatment spread to lymph nodes or distant organs.
London, EnglandAges Up to 90 years - NCT01301885Recruiting
Tests new diagnosis and treatments for endometriosis
This trial studies people who definitely have endometriosis (confirmed by surgery and tissue testing) and compares them with people whose endometriosis was ruled out during laparoscopy. It aims to improve how endometriosis is diagnosed and to explore new treatment approaches.
HelsinkiAges 19–48 - NCT01492972RecruitingPhase 3
Lighter radiation, with or without hormone suppression
This Phase 3 trial tests whether giving a smaller amount of radiation (“hypo-fractionated” means fewer, larger sessions) can work as well as standard approaches for intermediate-risk prostate cancer. It also compares adding hormone therapy (“androgen suppression”) to radiation versus using radiation alone.
Scottsdale, ArizonaAges 18 years+ - NCT01668186Recruiting
Study of how peroxisome disorders change over time
This study follows people with peroxisome biogenesis disorders (PBD) or closely related enzyme/protein defects to learn how symptoms and health changes over time. It may help researchers better understand the condition and plan future treatments.
Montreal, QuebecAges Any age - NCT01890590Recruiting
CyberKnife radiation for early kidney cancer
This trial tests whether CyberKnife (high-precision radiation) can treat early-stage kidney cancer. It may help people avoid or delay more invasive treatments by targeting the tumor while protecting nearby organs.
Boston, MassachusettsAges 18 years+ - NCT02012699Recruiting
Cancer registry for people with or at risk of cancer
This trial collects health information and samples (a “cancer repository”) to help researchers study cancer and cancer risk. You may be able to join if you’ve had cancer before or if you’re at higher risk or have concerning findings.
Greenwood Village, ColoradoAges 19–110
Common questions
- How many kidney & urinary clinical trials are recruiting?
- Clin2 is tracking 4,514 recruiting nephrology & urology studies from the U.S. registry right now, out of 7,211 we cover in this area in total.
- What does “Kidney & urinary” cover here?
- Kidney disease and conditions of the bladder and urinary tract. We group each study into kidney & urinary based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a kidney & urinary trial near me?
- Use the search to filter kidney & urinary studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.